Biomerica Statistics
Total Valuation
Biomerica has a market cap or net worth of $7.49 million. The enterprise value is $3.03 million.
| Market Cap | 7.49M |
| Enterprise Value | 3.03M |
Important Dates
The next estimated earnings date is Friday, August 23, 2024, after market close.
| Earnings Date | Aug 23, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Biomerica has 16.82 million shares outstanding. The number of shares has increased by 24.78% in one year.
| Shares Outstanding | 16.82M |
| Shares Change (YoY) | +24.78% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.30% |
| Owned by Institutions (%) | 27.93% |
| Float | 15.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.38 |
| Forward PS | n/a |
| PB Ratio | 0.96 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.44, with a Debt / Equity ratio of 0.11.
| Current Ratio | 4.44 |
| Quick Ratio | 3.24 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -64.00% and return on invested capital (ROIC) is -77.00%.
| Return on Equity (ROE) | -64.00% |
| Return on Assets (ROA) | -51.00% |
| Return on Capital (ROIC) | -77.00% |
| Revenue Per Employee | $87,181 |
| Profits Per Employee | -$102,406 |
| Employee Count | 62 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.28 |
Taxes
In the past 12 months, Biomerica has paid $48,014 in taxes.
| Income Tax | 48,014 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.50% in the last 52 weeks. The beta is -0.98, so Biomerica's price volatility has been lower than the market average.
| Beta (5Y) | -0.98 |
| 52-Week Price Change | -65.50% |
| 50-Day Moving Average | 0.58 |
| 200-Day Moving Average | 0.87 |
| Relative Strength Index (RSI) | 34.03 |
| Average Volume (20 Days) | 83,603 |
Short Selling Information
The latest short interest is 169,455, so 1.01% of the outstanding shares have been sold short.
| Short Interest | 169,455 |
| Short Previous Month | 175,151 |
| Short % of Shares Out | 1.01% |
| Short % of Float | 1.09% |
| Short Ratio (days to cover) | 3.00 |
Income Statement
In the last 12 months, Biomerica had revenue of $5.41 million and -$6.35 million in losses. Loss per share was -$0.37.
| Revenue | 5.41M |
| Gross Profit | 616,807 |
| Operating Income | -6.68M |
| Pretax Income | -6.30M |
| Net Income | -6.35M |
| EBITDA | -5.94M |
| EBIT | -6.30M |
| Loss Per Share | -$0.37 |
Balance Sheet
The company has $5.32 million in cash and $862,000 in debt, giving a net cash position of $4.46 million or $0.26 per share.
| Cash & Cash Equivalents | 5.32M |
| Total Debt | 862,000 |
| Net Cash | 4.46M |
| Net Cash Per Share | $0.26 |
| Equity (Book Value) | 7.81M |
| Book Value Per Share | 0.46 |
| Working Capital | 6.86M |
Cash Flow
In the last 12 months, operating cash flow was -$5.28 million and capital expenditures -$27,140, giving a free cash flow of -$5.31 million.
| Operating Cash Flow | -5.28M |
| Capital Expenditures | -27,140 |
| Free Cash Flow | -5.31M |
| FCF Per Share | -$0.32 |
Margins
Gross margin is 11.41%, with operating and profit margins of -123.51% and -117.46%.
| Gross Margin | 11.41% |
| Operating Margin | -123.51% |
| Pretax Margin | -116.58% |
| Profit Margin | -117.46% |
| EBITDA Margin | -109.91% |
| EBIT Margin | -116.58% |
| FCF Margin | -98.18% |
Dividends & Yields
Biomerica does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.78% |
| Shareholder Yield | -24.78% |
| Earnings Yield | -84.82% |
| FCF Yield | -70.89% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 14, 1994. It was a reverse split with a ratio of 1:2.
| Last Split Date | Nov 14, 1994 |
| Split Type | Reverse |
| Split Ratio | 1:2 |
Scores
Biomerica has an Altman Z-Score of -5.25 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.25 |
| Piotroski F-Score | 3 |